{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:43:21Z","timestamp":1781664201059,"version":"3.54.5"},"reference-count":106,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.drugpo.2015.09.005","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T03:51:19Z","timestamp":1443239479000},"page":"1177-1182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use"],"prefix":"10.1016","volume":"26","author":[{"given":"Benedikt","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharan","family":"Kuganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gallassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Malcher-Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.drugpo.2015.09.005_bib0005","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2007.04.049","article-title":"Crack whips the heart: A review of the cardiovascular toxicity of cocaine","volume":"100","author":"Afonso","year":"2007","journal-title":"The American Journal of Cardiology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0010","first-page":"281","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: A randomized clinical trial","volume":"71","author":"Allsop","year":"2014","journal-title":"Journal of the American Medical Association of Psychiatry"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pnpbp.2012.10.024","article-title":"Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test","volume":"41","author":"Almeida","year":"2013","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0020","series-title":"Pan-African issues in drugs and drug control: An international perspective","article-title":"Chapter 12: Drugs and drug control in Brazil","author":"Alves","year":"2015"},{"issue":"12","key":"10.1016\/j.drugpo.2015.09.005_bib0025","first-page":"CD003352","article-title":"Dopamine agonists for the treatment of cocaine dependence","volume":"7","author":"Amato","year":"2011","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.drugpo.2015.09.005_bib0030","first-page":"382","article-title":"\u2018What a pity!\u2019 \u2013 Exploring the use of \u2018pitilho\u2019 as harm reduction among crack users in Salvador, Brazil","volume":"18","author":"Andrade","year":"2011","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0035","series-title":"Pesquisa nacional sobre o uso de crack: Quem s\u00e3o os usu\u00e1rios de crack e\/ou similares do brasil? quantos s\u00e3o nas capitais brasileiras?","author":"Bastos","year":"2014"},{"issue":"1-2","key":"10.1016\/j.drugpo.2015.09.005_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","article-title":"Cannabinoids in medicine: A review of their therapeutic potential","volume":"105","author":"Ben Amar","year":"2006","journal-title":"Journal of Ethnopharmacology"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.avb.2008.02.001","article-title":"The statistical association between drug misuse and crime: A meta-analysis","volume":"13","author":"Bennett","year":"2008","journal-title":"Aggression and Violent Behavior"},{"issue":"6","key":"10.1016\/j.drugpo.2015.09.005_bib0050","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00426828","article-title":"Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice","volume":"49","author":"Bhargava","year":"1976","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(99)00094-0","article-title":"Sex related HIV risk behaviors: Differential risks among injection drug users, crack smokers, and injection drug users who smoke crack","volume":"58","author":"Booth","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.drugpo.2015.09.005_bib0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.drugpo.2009.12.008","article-title":"Women's health and use of crack cocaine in context: Structural and \u2018everyday\u2019 violence","volume":"21","author":"Bungay","year":"2010","journal-title":"International Journal of Drug Policy"},{"issue":"9","key":"10.1016\/j.drugpo.2015.09.005_bib0075","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1590\/S1807-59322009000900006","article-title":"Crack cocaine use and its relationship with violence and HIV","volume":"64","author":"Carvalho","year":"2009","journal-title":"Clinics"},{"issue":"5","key":"10.1016\/j.drugpo.2015.09.005_bib0080","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: A case series","volume":"39","author":"Chagas","year":"2014","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"6","key":"10.1016\/j.drugpo.2015.09.005_bib0085","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1590\/S0034-89102011005000066","article-title":"Crack cocaine craving: Behaviors and coping strategies among current and former users","volume":"45","author":"Chaves","year":"2011","journal-title":"Revista De Saude Publica"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pop.2010.11.004","article-title":"Stimulant abuse: Pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy","volume":"38","author":"Ciccarone","year":"2011","journal-title":"Primary Care"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0376-8716(99)00126-X","article-title":"Acute and protracted cocaine abstinence in an outpatient population: A prospective study of mood, sleep and withdrawal symptoms","volume":"59","author":"Coffey","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.drugpo.2015.09.005_bib0100","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/QAD.0b013e32830507f2","article-title":"Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV positive women","volume":"22","author":"Cook","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pu.17.050196.001355","article-title":"Crack cocaine abuse: An epidemic with many public health consequences","volume":"17","author":"Cornish","year":"1996","journal-title":"Annual Review of Public Health"},{"issue":"1-2","key":"10.1016\/j.drugpo.2015.09.005_bib0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/15433710903175858","article-title":"Case management outcomes for women who use crack","volume":"7","author":"Corsi","year":"2010","journal-title":"Journal of Evidence-Based Social Work"},{"issue":"4","key":"10.1016\/j.drugpo.2015.09.005_bib0115","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.mehy.2006.09.030","article-title":"Potential therapeutical effects of cannabidiol in children with pharmacoresistant epilepsy","volume":"68","author":"Cortesi","year":"2007","journal-title":"Medical Hypotheses"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jcpt.12018","article-title":"Cannabidiol for the treatment of cannabis withdrawal syndrome: A case report","volume":"38","author":"Crippa","year":"2013","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"issue":"9810","key":"10.1016\/j.drugpo.2015.09.005_bib0535","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"issue":"2-3","key":"10.1016\/j.drugpo.2015.09.005_bib0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2010.07.026","article-title":"Mortality among cocaine users: A systematic review of cohort studies","volume":"113","author":"Degenhardt","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugpo.2015.09.005_bib0145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"issue":"3-4","key":"10.1016\/j.drugpo.2015.09.005_bib0150","doi-asserted-by":"crossref","DOI":"10.1300\/J175v02n03_08","article-title":"Crack heads and roots daughters: The therapeutic use of cannabis in Jamaica","volume":"2","author":"Dreher","year":"2002","journal-title":"Journal of Cannabis Therapeutics"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-011-2566-z","article-title":"Anxiogenic-like effects of chronic cannabidiol administration in rats","volume":"221","author":"ElBatsh","year":"2012","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.drugpo.2015.09.005_bib0160","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/02791072.2003.10400494","article-title":"Current physical health problems and their predictors among a community sample of crack-cocaine smokers in Ohio","volume":"35","author":"Falck","year":"2003","journal-title":"Journal of Psychoactive Drugs"},{"issue":"7","key":"10.1016\/j.drugpo.2015.09.005_bib0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.nmd.0000131913.94916.d5","article-title":"The prevalence of psychiatric disorder among a community sample of crack cocaine users: An exploratory study with practical implications","volume":"192","author":"Falck","year":"2004","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/10550887.2013.824328","article-title":"A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence","volume":"32","author":"Farronato","year":"2013","journal-title":"Journal of Addictive Diseases"},{"issue":"10","key":"10.1016\/j.drugpo.2015.09.005_bib0175","first-page":"613","article-title":"Cannabinoid drugs for neurological diseases: What is behind? [Farmacos cannabinoides para las enfermedades neurologicas?]","volume":"54","author":"Fernandez-Ruiz","year":"2012","journal-title":"Revista De Neurologia"},{"issue":"4","key":"10.1016\/j.drugpo.2015.09.005_bib0180","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2015.01.002","article-title":"Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: A comprehensive narrative overview of English-language studies","volume":"26","author":"Fischer","year":"2015","journal-title":"The International Journal on Drug Policy"},{"issue":"9","key":"10.1016\/j.drugpo.2015.09.005_bib0185","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1360-0443.2007.01963.x","article-title":"Crack use in North American cities: The neglected \u2018epidemic\u2019","volume":"102","author":"Fischer","year":"2007","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.drugpo.2015.09.005_bib0190","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.drugpo.2013.09.003","article-title":"Crack across the Americas \u2013 A massive problem in continued search of viable answers: Exemplary views from the North (Canada) and the South (Brazil)","volume":"24","author":"Fischer","year":"2013","journal-title":"The International Journal of Drug Policy"},{"issue":"12","key":"10.1016\/j.drugpo.2015.09.005_bib0195","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1360-0443.2006.01614.x","article-title":"Crack across Canada: Comparing crack and non-crack users in a multi-city cohort of opioid and other street drug users","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"issue":"1-3","key":"10.1016\/j.drugpo.2015.09.005_bib0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2008.07.004","article-title":"Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals","volume":"99","author":"Ford","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of {delta} 9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0210","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1186\/s12889-015-2063-0","article-title":"Factors that lead to the use of crack cocaine in combination with marijuana in Brazil: A qualitative study","volume":"15","author":"Goncalves","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1874205X01206010018","article-title":"Medical marijuana: Clearing away the smoke","volume":"6","author":"Grant","year":"2012","journal-title":"The Open Neurology Journal"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0740-5472(03)00128-4","article-title":"Predictors of drug treatment re-entry following relapse to cocaine use in DATOS","volume":"25","author":"Grella","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.drugpo.2015.09.005_bib0225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1162\/003465300558957","article-title":"The emergence of crack cocaine and the rise in urban crime rates","volume":"82","author":"Grogger","year":"2000","journal-title":"The Review of Economics and Statistics"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.107.1.233","article-title":"The pulmonary complications of crack cocaine: A comprehensive review","volume":"107","author":"Haim","year":"1995","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.drugpo.2015.09.005_bib0235","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1080\/10826080500391613","article-title":"Effectiveness of an outreach treatment program for inner city crack abusers: Compliance, outcome, and client satisfaction","volume":"43","author":"Henskens","year":"2008","journal-title":"Substance Use and Misuse"},{"issue":"16","key":"10.1016\/j.drugpo.2015.09.005_bib0540","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJMp1000695","article-title":"Medical marijuana and the law","volume":"362","author":"Hoffmann","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0740-5472(95)02020-9","article-title":"Psychosocial treatments for cocaine abuse: 12-month treatment outcomes","volume":"13","author":"Hoffman","year":"1996","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1-3","key":"10.1016\/j.drugpo.2015.09.005_bib0250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1016\/j.drugpo.2015.09.005_bib0255","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.drugpo.2011.05.005","article-title":"Uptake, benefits of and barriers to safer crack use kit (SCUK) distribution programmes in Victoria, Canada \u2013 A qualitative exploration","volume":"22","author":"Ivsins","year":"2011","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.drugpo.2015.09.005_bib0260","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11920-010-0143-5","article-title":"What's new in the treatment of cocaine addiction?","volume":"12","author":"Kampman","year":"2010","journal-title":"Current Psychiatry Reports"},{"issue":"14","key":"10.1016\/j.drugpo.2015.09.005_bib0265","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2174\/138161211796150873","article-title":"Pharmacological treatments for cocaine dependence: Is there something new?","volume":"17","author":"Karila","year":"2011","journal-title":"Current Pharmaceutical Design"},{"issue":"8-9","key":"10.1016\/j.drugpo.2015.09.005_bib0270","doi-asserted-by":"crossref","first-page":"437S","DOI":"10.1002\/j.1552-4604.1981.tb02624.x","article-title":"The cannabinoids as potential antiepileptics?","volume":"21","author":"Karler","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0275","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol inhibits the reward-facilitating effect of morphine: Involvement of 5-HT1A receptors in the dorsal raphe nucleus","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addiction Biology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0280","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10461-012-0276-0","article-title":"Non-injection and injection drug use and STI\/HIV risks in the United States: The degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users","volume":"17","author":"Khan","year":"2013","journal-title":"AIDS and Behavior"},{"issue":"17","key":"10.1016\/j.drugpo.2015.09.005_bib0285","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the guideline development subcommittee of the American academy of neurology","volume":"82","author":"Koppel","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.drugpo.2015.09.005_bib0290","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/02791072.1999.10471776","article-title":"Therapeutic use of cannabis by crack addicts in Brazil","volume":"31","author":"Labigalini","year":"1999","journal-title":"Journal of Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.drugpo.2015.09.005_bib0295","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM200108023450507","article-title":"Cardiovascular complications of cocaine use","volume":"345","author":"Lange","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0300","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Translational Psychiatry"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0305","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF03404893","article-title":"Do crack smoking practices change with the introduction of safer crack kits?","volume":"102","author":"Malchy","year":"2011","journal-title":"Canadian Journal of Public Health"},{"issue":"12","key":"10.1016\/j.drugpo.2015.09.005_bib0310","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1590\/S1413-81232011001300026","article-title":"Behavior and major barriers faced by non-injectable drug users with HBV\/HCV seeking treatment for hepatitis and drug addiction in Rio de Janeiro, Brazil","volume":"16","author":"Malta","year":"2011","journal-title":"Ciencia & Saude Coletiva"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0315","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.drugpo.2015.09.005_bib0320","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1037\/0022-006X.66.5.832","article-title":"Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: Main and matching effects","volume":"66","author":"Maude-Griffin","year":"1998","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"5","key":"10.1016\/j.drugpo.2015.09.005_bib0325","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.janxdis.2009.01.006","article-title":"The role of anxiety sensitivity and difficulties in emotion regulation in posttraumatic stress disorder among crack\/cocaine dependent patients in residential substance abuse treatment","volume":"23","author":"McDermott","year":"2009","journal-title":"Journal of Anxiety Disorders"},{"issue":"11","key":"10.1016\/j.drugpo.2015.09.005_bib0330","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: An overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1016\/j.drugpo.2015.09.005_bib0335","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2105\/AJPH.2004.039743","article-title":"To house or not to house: The effects of providing housing to homeless substance abusers in treatment","volume":"95","author":"Milby","year":"2005","journal-title":"American Journal of Public Health"},{"issue":"9","key":"10.1016\/j.drugpo.2015.09.005_bib0340","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0345","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0033291711001322","article-title":"Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being","volume":"42","author":"Morgan","year":"2012","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0350","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1176\/appi.ajp.2009.09050613","article-title":"Normalizing effects of modafinil on sleep in chronic cocaine users","volume":"167","author":"Morgan","year":"2010","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0355","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-244X-11-135","article-title":"Cocaine addiction treatments to improve control and reduce harm (CATCH): New pharmacological treatment options for crack-cocaine dependence in the Netherlands","volume":"11","author":"Nuijten","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0360","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2014.02.024","article-title":"Treatment of crack-cocaine dependence with topiramate: A randomized controlled feasibility trial in the Netherlands","volume":"138","author":"Nuijten","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugpo.2015.09.005_bib0365","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0269881115582151","article-title":"Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial","volume":"29","author":"Nuijten","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0370","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0269881111410899","article-title":"Through a glass darkly: Can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?","volume":"26","author":"Nutt","year":"2012","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0375","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0380","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1038\/sj.bjp.0706406","article-title":"Cannabinoid pharmacology: The first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"11","key":"10.1016\/j.drugpo.2015.09.005_bib0385","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","article-title":"Contingency management for treatment of substance use disorders: A meta-analysis","volume":"101","author":"Prendergast","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0390","first-page":"33","article-title":"Cannabidiol as an intervention for addictive behaviors: A systematic review of the evidence","volume":"9","author":"Prud\u2019homme","year":"2015","journal-title":"Substance Abuse: Research and Treatment"},{"issue":"5","key":"10.1016\/j.drugpo.2015.09.005_bib0395","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1590\/S1413-81232011000500031","article-title":"Crack usage circuits in the downtown area of the city of S\u00e3o Paulo","volume":"16","author":"Raupp","year":"2011","journal-title":"Ci\u00eancia & Sa\u00fade Coletiva"},{"issue":"47","key":"10.1016\/j.drugpo.2015.09.005_bib0400","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a non-psychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0405","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/1471-2458-10-671","article-title":"Surviving crack: A qualitative study of the strategies and tactics developed by Brazilian users to deal with the risks associated with the drug","volume":"10","author":"Ribeiro","year":"2010","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.drugpo.2015.09.005_bib0410","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0740-5472(95)02013-6","article-title":"Effectiveness of adjunct therapies in crack cocaine treatment","volume":"12","author":"Richard","year":"1995","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.drugpo.2015.09.005_bib0415","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2105\/AJPH.94.7.1207","article-title":"HIV seroprevalence among homeless and marginally housed adults in San Francisco","volume":"94","author":"Robertson","year":"2004","journal-title":"American Journal of Public Health"},{"issue":"1-2","key":"10.1016\/j.drugpo.2015.09.005_bib0420","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/dta.1529","article-title":"Therapeutic potential of cannabinoid medicines","volume":"6","author":"Robson","year":"2014","journal-title":"Drug Testing and Analysis"},{"issue":"7","key":"10.1016\/j.drugpo.2015.09.005_bib0425","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0430","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-13-536","article-title":"Patterns, determinants and barriers of health and social service utilization among young urban crack users in Brazil","volume":"13","author":"Santos Cruz","year":"2013","journal-title":"BMC Health Services Research"},{"issue":"5","key":"10.1016\/j.drugpo.2015.09.005_bib0435","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.drugpo.2013.03.012","article-title":"Key drug use, health and socio-economic characteristics of young crack users in two Brazilian cities","volume":"24","author":"Santos Cruz","year":"2013","journal-title":"The International Journal on Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.11.014","article-title":"Non-injection drug use and hepatitis C virus: A systematic review","volume":"89","author":"Scheinmann","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0445","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2011.02.019","article-title":"Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children","volume":"118","author":"Schottenfeld","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2015.09.005_bib0450","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.euroneuro.2013.11.002","article-title":"Cannabidiol as a potential treatment for psychosis","volume":"24","author":"Schubart","year":"2014","journal-title":"European Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.drugpo.2015.09.005_bib0455","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ptr.2625","article-title":"Cannabidiol in medicine: A review of its therapeutic potential in CNS disorders","volume":"23","author":"Scuderi","year":"2009","journal-title":"Phytotherapy Research: PTR"},{"issue":"8","key":"10.1016\/j.drugpo.2015.09.005_bib0460","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","article-title":"Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence","volume":"98","author":"Shearer","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0465","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1741-7015-9-119","article-title":"Novel pharmacotherapeutic treatments for cocaine addiction","volume":"9","author":"Shorter","year":"2011","journal-title":"BMC Medicine"},{"issue":"9","key":"10.1016\/j.drugpo.2015.09.005_bib0470","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3201\/eid1409.070654","article-title":"Crack cocaine and infectious tuberculosis","volume":"14","author":"Story","year":"2008","journal-title":"Emerging Infectious Diseases"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0475","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11904-010-0043-7","article-title":"Epidemiology of HIV among injecting and non-injecting drug users: Current trends and implications for interventions","volume":"7","author":"Strathdee","year":"2010","journal-title":"Current HIV\/AIDS Reports"},{"issue":"7","key":"10.1016\/j.drugpo.2015.09.005_bib0480","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1465-3362.2012.00446.x","article-title":"Factors associated with difficulty accessing crack cocaine pipes in a Canadian setting","volume":"31","author":"Ti","year":"2012","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0485","series-title":"World Drug Report 2014. (No. E.15.XI.6)","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2015"},{"issue":"4","key":"10.1016\/j.drugpo.2015.09.005_bib0490","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1024\/2005.04.01","article-title":"Epidemiology of cocaine and crack: Implications for drug policy and treatment planning","volume":"51","author":"Van den Brink","year":"2005","journal-title":"Sucht"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0495","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/02791072.2006.10399836","article-title":"Drug users\u2019 participation in addiction care: Different groups do different things","volume":"38","author":"van der Poel","year":"2006","journal-title":"Journal of Psychoactive Drugs"},{"issue":"9","key":"10.1016\/j.drugpo.2015.09.005_bib0500","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1017\/S1368980009993181","article-title":"Food insufficiency among HIV-infected crack-cocaine users in Atlanta and Miami","volume":"13","author":"Vogenthaler","year":"2010","journal-title":"Public Health Nutrition"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0505","series-title":"The biology and potential therapeutic effects of cannabidiol: Testimony before the Senate Caucus on International Narcotics Control United States Senate, June 24, 2015","author":"Volkow","year":"2015"},{"key":"10.1016\/j.drugpo.2015.09.005_bib0510","series-title":"Crack cocaine: A practical treatment approach for the chemically dependent","author":"Wallace","year":"2014"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0515","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1465-3362.2009.00145.x","article-title":"Modelling crack cocaine use trends over 10 years in a Canadian setting","volume":"29","author":"Werb","year":"2010","journal-title":"Drug and Alcohol Review"},{"issue":"24","key":"10.1016\/j.drugpo.2015.09.005_bib0520","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: A systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1016\/j.drugpo.2015.09.005_bib0525","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Revista Brasileira De Psiquiatria"},{"issue":"2","key":"10.1016\/j.drugpo.2015.09.005_bib0530","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacology"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539591500300X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539591500300X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T09:15:11Z","timestamp":1653210911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095539591500300X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":106,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S095539591500300X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.09.005","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}